Acute coronary syndrome Flashcards

1
Q

Explain the pathogenesis of acute coronary syndrome!

A

Most of ACS result from the disruption of an atherosclerotic plaque wit subsequent platelet aggregation and formation of an intracoronary thrombus. The form of ACS that result depends on the degree of coronary obstruction and associated ischemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the normal hemostasis! What is the difference between primary and secondary hemostas?

A

When a normal blood vessel is injured, the endothelial surface becomes disrupted and thrombogenic connective tissue is exposed. Hemostasis begins within seconds of vessel injury and is mediated by circulating platelets, which adhere to collagen in the vascular subendothelium and aggregate to form a “platelet plug”. While the primary hemostatic plug forms, the exposure of subendothelial tissue factor triggers the plasma coagulation cascade, initiating the process of secondary hemostasis. The plasma coagulation proteins form a fibrin clot by the action of thrombin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is anti-thrombin and how does it work?

A

Anti-thrombin is a plasma protein that irreversibly bind to thrombin and other clotting factors, inactivating them and facilitating their clearance from the circulation. The effectiveness of antithrombin is increased by binding to heparin sulfate.
Protein C, protein S, and thrombomodulin – inactivates the “acceleration”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do protein C, protein S and thrombomodulin work? Where are they synthesised?

A

Protein C, protein S, and thrombomodulin – inactivates the “acceleration” factors of the coagulation pathway (factor Va and VIIIa). Protein C is synthesized in the liver and circulated in an inactive form. Thrombomodulin is a thrombin-binding receptor normally present on endothelial cells. Thrombin bound to thrombomodulin can’t covert fibrinogen to fibrin. Instead, the thrombin-thrombomodulin complex activated protein C (which degrades Va and VIIIa). Protein S enhances inhibitory function of protein C.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Tissue factor pathway inhibitor?How does it work?

A

TFPI is a plasma serine protease inhibitor that is activated by coagulation factor Xa. The combined factor Xa–TFPI binds to and inactivates the complex of tissue factor with factor VIIa that normally triggers the extrinsic coagulation pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give an example of a protein that lysis fibrin clot! How does it work?

A

Tissue plasminogen activator (tPA) is a protein secreted by endothelial cells in response to many triggers of clot formation. It cleaves plasminogen to form plasmin, which in turn enzymatically degrade fibrin clots. When tPA binds to fibrin, its activity enhances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List couple of endogenous anti-thrombotic mechanism!

A

Anti-thrombin, protein C, protein S, thrombomodulin, TFPI, lysis of fibrin clot, endogenous platelet inhibition and vasodilation including prostaglandin I2 and NO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does prostaglandin I2 work?

A

Prostaglandin I2 increases platelet level of cyclic AMP and thereby strongly inhibit platelet activation and aggregation. It indirectly inhibits coagulation via its potent vasodilating properties (augmenting blood flow and reducing shear stress).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does NO work as an anithromb?

A

NO act locally to inhibit platelet activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What causes plaque disruption?

A

The causes of plaque disruption are (1) chemical factors that destabilize atherosclerotic lesion and (2) physical stresses to which the lesions are subjected. Substance released from inflammatory cells within the plaque can compromise the integrity of the fibrous cap (T-cell produce INF-γ which inhibits collagen synthesis by smooth muscle cells and thereby interferes with the usual strength of the cap). Additionally, cells within atherosclerotic lesions produce enzyme that degrade the interstitial matrix.
The activation of the sympathetic nervous system increases the blood pressure, heart rate, and the force of ventricular contraction – actions that may stress the atherosclerotic lesion, thereby cause the plaque to fissure or rupture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What activates platelets? What do platelets release once activated?

A

Activated platelets release the contents of their granules, which include facilities of platelets aggregation (ADP and fibrinogen), activators of coagulation cascade (factor Va), and vasoconstrictors (thromboxane and serotonin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List couple of non-atherosclerotic cause of acute myocardial infarction!

A

Coronary emboli from mechanical or infected cardiac valves may lodge in the coronary circulation, inflammation from acute vasculitis can initiate coronary occlusion, or patients with connective tissue disorders, or peripartum women, can rarely experience a spontaneous coronary artery dissection (a tear in the vessel wall that may lead to occlusion).
Cocaine increases sympathetic tone (HR and BP) by blocking the presynaptic reuptake of the noradrenaline and enhancing the release of adrenal catecholamines, which can lead to vasospasm and therefore decrease in myocardial oxygen supply.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which part of the heart that is most subject to ischemia?

A

Transmural infarcts span the entire thickness of the myocardial wall and result from total, prolonged occlusion of an epicardial coronary artery. Conversely, subendocardial infarcts exclusively involve the innermost layers of the myocardium. The subendocardium is particularly susceptible to ischemia because it is the zone subjected to the highest pressure from the ventricular chamber, has few collateral connections that supply it, and is perfused by vessels that must pass through layers of contracting myocardium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What determines if the tissue will go necrosis during vessel occlusion?

A

(1) mass of the myocardium perfused by the occluded vessel, (2) the magnitude and duration of occluded vessel, (3) the oxygen demand of the affected region, (4) the adequacy of collateral vessel (5) the degree of tissue response that modifies the ischemic process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Explain the pathological evolution of infarction after:
1-2 min
10 min
20-24 min
1-3 h 
4-12 h
18-24h
2-4 d
5-7 days
7+ days
7 wks
A

Early changes

1–2 min ATP levels fall; cessation of contractility

10 min 50% depletion of ATP; cellular edema, decreased membrane potential, and susceptibility to arrhythmias

20–24 min Irreversible cell injury

1–3 h Wavy myofibers

4–12 h Hemorrhage, edema, PMN infiltration begins

18–24 h Coagulation necrosis (pyknotic nuclei with eosinophilic cytoplasm), edema

2–4 d Total coagulation necrosis (no nuclei or striations, rimmed by hyperemic tissue); monocytes appear; PMN infiltration peaks

Late changes

5–7 d Yellow softening from resorption of dead tissue by macrophages

7+ d Granulation tissue forms, ventricular remodeling

7 wk Fibrosis and scarring complete

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the early changes in infarction?

A

As oxygen levels fall in the myocardium supplied by an occluded coronary vessel, there is a rapid shift from aerobic to anaerobic metabolism. Because mitochondria can no longer oxidize fats or products of glycolysis. Anaerobic glycolysis leads to the accumulation of lactic acid, resulting in a lowered pH.
The decrease in ATP concentration will impair the Na+-K+-ATPase, with resultant elevation in the concentrations of intracellular Na+ (cause cellular edema- develops within 4-12 hours) and extracellular K+ (contributes to alteration in transmembrane electrical potential, predisposing the myocardium to lethal arrhythmias). Intracellular calcium accumulates and cause the activation of lipases and proteases. Proteolytic enzyme leak across the myocyte’s altered membrane, damaging adjacent myocardium.
Contraction band can be seen near the border of the infarct: sarcomeres are contracted and consolidated.
Acute inflammatory response begins after 4 hours and causes further damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the later changes in infarction?

A
These include (1) the clearing of necrotic myocardium and (2) the deposition of collagen to form scar tissue. Irreversibly injured myocytes do not regenerate; rather, the cells are removed and replaced by fibrous tissue. Macrophages invade the inflamed myocardium shortly after neutrophil infiltration and remove necrotic tissue. The phagocytic clearing, combined with the thinning and dilation of the infarcted zone, results in structural weakness of the ventricular wall and the possibility of myocardial wall rupture. 
1 week after infarction, granulation tissue appears, representing the beginning of the scarring process.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does hypokinetic, akinetic and dyskinetic means?

A
  • Hypokinetic – a localized region of reduced contraction
  • Akinetic – a segment that doesn’t contract
  • Dyskinetic – is one that bulges outward during contraction of the remaining functional portion of the ventricle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain the process of ventricular remodeling works?

A

In the early post-MI period, infarct expansion may occur, in which the affected ventricular segment enlarges without additional myocytes necrosis. Infarct expansion represents thinning and dilation of the necrotic zone of tissue. Infarct expansion can be detrimental because it increases ventricular size, which (1) augments wall stress, (2) impairs systolic contractile function, and (3) increases the likelihood of aneurysm.
Remodeling of the ventricle may also involve dilation of the overworked noninfarcted segment, which is subjected to increased wall stress. Initially, chamber dilatation serves a compensatory role because it increases cardiac output via the frank-starling mechanism, but progressive enlargement may lead to heart failure and ventricular arrhythmias.
Intervention that stop ventricular remodeling can reduce short- and long-term mortality after infarction (these include renin-angiotensin antagonist).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the consequences of ventricular wall dilation and thinning?

A

(1) augments wall stress, (2) impairs systolic contractile function, and (3) increases the likelihood of aneurysm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the clinical presentation of acute myocardial infarction?

A

The discomfort experienced during an Mi resembles angina pectoris qualitatively but is usually more severe, last longer, and may radiate more widely. The sensation may result from the release of mediators such as adenosine and lactate from ischemic myocardial cells onto local nerve endings. The discomfort is often referred to other regions of the C7 through T4 dermatomes. The pain doesn’t wane with rest, and there may be little response to administration of sublingual nitroglycerin.
Up to 25% of patient who sustain an MI are asymptomatic, this is common among diabetic patients who may not sense pain because of associated neuropathy.

The combination of intense discomfort and baroceptor unloading (if hypertension is present) may trigger sympathetic nervous system response. This can cause diaphoresis (sweating), tachycardia, and cool and clammy skin cause by vasoconstriction.
If the ischemia affects a large amount of myocardium, left ventricular contractility can be reduced thereby decreasing the stoke volume and causing the diastolic volume and pressure within the LV to rise. The increase in LV pressure, compounded by the ischemia-induced stiffness of the chamber, is conveyed to the left atrium and pulmonary veins. The resultant pulmonary congestion decreases lung compliance and stimulate juxtacapillary receptors. The J receptor effect a reflex that results in rapid, shallow breathing and evokes the subject feeling of dyspnea.

22
Q

What are the physical finding of MI?

A

Physical finding during an acute MI depends on the location and extent of the infarct. The S4 sound is presented, this indicate that the atrial is contracting into a noncompliant left ventricle. An S3 sound, indicative of volume overload in the presence of failing LV systolic function, may be also heard. A systolic murmur may appear if the ischemia-induced papillary muscle dysfunction causes mitral valvular insufficiency.
Myocardial necrosis activates systemic response to inflammation. Cytokines (IL-1 and TNF) are released from macrophages and endothelial cells.

23
Q

What are signs and symptom of MI

A

Characteristic pain: Severe, persistent, typically substernal

Sympathetic effect - Diaphoresis
- Cool and clammy skin

Parasympathetic (vagal effect) - Nausea, vomiting
- Weakness

Inflammatory response Mild fever

Cardiac findings - S4 (and S3 if systolic dysfunction present) gallop
- Dyskinetic bulge (in anterior wall MI)
- Systolic murmur (if mitral regurgitation or VSD)
Other - Pulmonary rales (if heart failure present)
- Jugular venous distention (if heart failure or right ventricular MI)

24
Q
what are the
- typical symtoms 
-Serum biomarker
-EKG finding 
in unstable angina
A

Typical symptoms: Crescendo, rest, or new-onset severe angina

Serum biomarkers: No

Electrocardiogram initial findings: ST depression and/or T-wave inversion

25
Q
what are the
- typical symtoms 
-Serum biomarker
-EKG finding 
in NSTEMI
A

Typical symptoms:Prolonged “crushing” chest pain, more severe and wider radiation than usual angina

Serum biomarkers: yes

Electrocardiogram initial findings: ST depression and/or T-wave inversion

26
Q
what are the
- typical symtoms 
-Serum biomarker
-EKG finding 
in STEMI
A

Typical symptoms:Prolonged “crushing” chest pain, more severe and wider radiation than usual angina

Serum biomarkers: yes

Electrocardiogram initial findings: ST elevation (and Q waves later)

27
Q

What are the serum markers of infarction? Explain their presentation!

A

Cardiac-specific troponins
The cardiac forms of troponin I and troponin T are structural unique. In case of MI, cardiac troponin serum levels begin to rise 3 to 4 hours after the onset of chest discomfort, achieve a peak level between 18 and 36 hours and then decline slowly, allowing for detection for 10 days after a large MI.
Creatine kinase
The enzyme is found in the brain (CK-BB), skeletal (CK-MM) and cardiac muscle (CK-MB) but in different isomers. To facilitate the diagnosis of MI using this marker, it is common to calculate the ratio of CK-MB and total CK. The ratio is usually greater than 2,5% in the setting of myocardial injury. The serum level of CK-MB starts to rise 3-8 hours following infarction, peaks at 24 hours, and return to normal within 48 to 72 hours.

28
Q

What are the acute treatment of unstable angina and non-ST-elevation myocardial infarction?

A

The primary focus of treatment of UA and NSTEMI consists of anti-ischemic, and antithrombotic therapy.
Anti-ischemic therapy
- Β-blocker which reduces oxygen demand and the likelihood of progression from UA to MI. β-blockers is used to achieve a target heart rate of 60 beats/min.
- Nitrates lower oxygen demand by diminishing venous return to the heart.
- Nondihydropyridine calcium channel antagonists – decrease the heart rate and contractility. They should not be prescribed to patients with LV systolic dysfunction.
Anti-thrombotic therapy
Antiplatelet drugs
- Aspirin – inhibits platelets synthesis of thromboxane A2, a potent mediators of platelet activation.
- Clopidogrel a platelet P2Y12 antagonist, it doesn’t allow ADP to bind to the receptor and activate platelets. Not all patient responds to this medication because it is a prodrug that requires cytochrome P-450- mediated biotransformation to its active metabolite.
- Prasugrel (same effects as clopidogrel) without the need of to produce the active metabolite. However, it is more potent and increases the risk of bleeding complication.
Both clopidogrel and prasugrel are irreversible platelet inhibitors. Drug such as ticagrelor is a nonthienopyridine drug that is a reversible P2Y12ADP receptor blocker.
- Glycoprotein (GP) IIb/IIa receptor antagonists are potent antiplatelet agents.

Anti-coagulant drugs

  • Intravenous unfractionated heparin – It bind to antithrombin, which greatly increases the potency of that plasma protein in the inactivation of clot-forming thrombin. UFH also inhibits coagulation factor Xa, slowing thrombin formation and thereby impeding clot development.
  • Low molecules weight heparins (LMWHs) same as UFH but taken by subcutaneous injection. In clinical trials, it demonstrated to reduce death and ischemic events rate compared with UFH.
  • Bivalirudin is an intravenous direct thrombin inhibitor, which is equivalent to UFH plus a GP IIb/IIIa inhibitor in preventing adverse ischemic outcomes, with less associated bleeding, in patients with UA or NSTEMI treated with an early invasive strategy.
  • Fondaparinux is a subcutaneously administered agent that is a very specific factor Xa inhibitor.
29
Q

what determines if a patient should get an invasive treatment in UA and NSTEMi?

A
  • Age greater than 65 years old.
  • > 3 risk factors for coronary artery disease
  • Known coronary stenosis of >50%
  • St-segment deviation on the EKG
  • At least two anginal episode in prior 24 hours.
  • Use of aspirin in prior 7 days (aspirin resistance)
  • Elevated serum troponin or CK-MB
30
Q

what are the acute treatment of ST-elevation myocardial infarction?

A

The major focus of acute treatment is to achieve very rapid reperfusion of the jeopardized myocardium using either percutaneous coronary mechanical revascularization or fibrinolytic drug. These approaches reduce the extent of myocardial necrosis and improve survival.
Medications are used to prevent further thrombosis and restore oxygen balance.
- Aspirin – decrease mortality rate and rate of reinfarction. It should be administered immediately on presentation (by chewing a tablet to facilitate absorption) and continued orally daily thereafter.
- Anticoagulant
- β-blockers – in the absence of contraindications (asthma, hypotension, or significant bradycardia), an oral β-blockers should be administrated to achieve a heart rate of 50 to 60 beats/min. Intravenous β-blockers therapy should be reserved for patients who are hypertensive, as that route of administration has otherwise been associated with an increased risk of cardiogenic shock in STEMI.
- Nitrate therapy – help control ischemic pain and serve as a beneficial vasodilator in patient

31
Q

How does fibrinolytic therapy work? give an example of a drug used!

A

Fibrinolytic therapy accelerates lysis of the occlusive intracoronary thrombus in STEMI, thereby restoring blood flow and limiting myocardial damage. Currently used fibrinolytic agents include recombinant tissue–type plasminogen activator (alteplase, tPA), reteplase (rPA), and tenecteplase (TNK-tPA). Each drug functions by stimulating the natural fibrinolytic system, transforming the inactive precursor plasminogen into the active protease plasmin, which lyses fibrin clots. Plasmin can degrade other proteins, including fibrin’s precursor fibrinogen. As a result, bleeding in the most common complication of this drug.

32
Q

List couple of adjunctive therapy in MI!

A
  • Angiotensin-converting enzyme ACE inhibitor – limit adverse ventricular remodeling and reduce the incidence of heart failure.
  • Cholesterol lowering statin – lowers LDL, improve endothelial dysfunction, inhibit platelet aggregation, and impair thrombus formation.
  • Ezetimibe
  • After the short-term use of heparin, a more prolonged course, followed by oral anticoagulation (warfarin), is appropriate for patients at high risk of thromboembolism.
    Impaired ventricular contractility after MI can lead to heart failure. Patient with a left ventricular ejection fraction of less than 40% and symptoms of heart failure after STEMI should be considered for therapy with an aldosterone antagonist in addition to an ACE inhibitor and β-blockers. Aldosterone augments sodium reabsorption from the distal nephron and promotes inflammation and myocardial fibrosis.
33
Q

List couple of complication after MI!

A

Recurrent ischemia – 20-30% of patients develop a postinfarction angina. Such patient requires urgent cardiac catheterization, often follow by revascularization by percutaneous technique or bypass.

Arrhythmias

34
Q

What causes arrhythmias after MI?

A

Mechanism that contribute to arrhythmogenesis after MI include the following:

  • Interruption of blood flow to structures of the conduction pathway (e.g., sinoatrial node, atrioventricular node, and bundle branches).
  • Accumulation of toxic product (e.g., cellular acidosis) and abnormal transcellular ion concertation owing to membrane leaks.
  • Autonomic stimulation (sympathetic and parasympathetic)
  • Administration of potential arrhythmogenic drugs (e.g., dopamine).
35
Q

Which artery supplies the SA node?

A

RCA

36
Q

Which artery supplies the AV node?

A

RCA

37
Q

Which artery supplies the bundle of His?

A

LAD

38
Q

Which artery supplies the right bundle branch?

A

proximal portion by LAD

Distal portion by RCA

39
Q

Which artery supplies the left anterior fascicle?

A

LAD

40
Q

Which artery supplies the left posterior fascicle?

A

LAD and PDA

41
Q

Explain the causes of supraventricilar arrhythmias!

A
  • Sinus bradycardia results from either excessive vagal stimulation or sinoatrial nodal ischemia, usually in the setting of an inferior wall MI.
  • Sinus tachycardia occurs frequently and may result from pain and anxiety, heart failure, drug administration (e.g., dopamine), or intravascular volume depletion.
  • Atrial premature beats and atrial fibrillation may result from atrial ischemia or atrial distention secondary to LV failure.
42
Q

Explain the causes of conduction block!

A

They may result from ischemia or necrosis of conduction tracts, or in the case of atrioventricular blocks, they may develop transiently because of increased vagal tone. Vagal activity may be increased because of stimulation of afferent fibers by the inflamed myocardium or because of generalized automatic activation in association with discomfort of an acute MI.

43
Q

Explain the process of cardiogenic shock! what are the advised treatment?

A

Cardiogenic shock – is severely decreased cardiac output and hypotension with inadequate perfusion of peripheral tissue that develops when more that 40% of the LV mass has infarcted. Cardiogenic shock is self-perpetuating because (1) hypotension lead to decrease coronary perfusion and (2) decreased stroke volume increases LV size and therefore augment myocardial oxygen demand.
Patient in cardiogenic shock required intravenous inotropic agents (e.g. dobutamine) to increase cardiac output and, once the blood pressure has improved, arterial vasodilators to reduce the resistance to LV contraction. Patient may be stabilized by the placement of an intra-aortic balloon pump. The pump consists of an inflatable, flexible chamber that expands during diastole to increase intra-aortic pressure, thus augmenting perfusion of the coronary arteries. During systole, it deflates to create a “vaccum” that serves to reduce the afterload of the left ventricle ´, thus aiding the ejection of blood

44
Q

What causes heart failure after MI?

A

Heart failure – result from an impaired ventricular contractility (systolic dysfunction) and increased myocardial stiffness (diastolic dysfunction). Ventricular remodeling, arrhythmias, and acute complications of MI may culminate in heart failure.

45
Q

What is common with LV inferior wall infarction? What does it leads to?

A

Right ventricular infarction – 1/3 of patient with infarction of LV inferior wall also develop necrosis of portions of the right ventricle, because the same coronary artery (usually the right coronary) perfuses both regions in most individuals. The resulting abnormal contraction and decrease compliance of the right ventricle lead to signs of right-sided heart failure (e.g., jugular venous distention) out of proportion to sign of left-sided failure. Profound hypotension may result when the right ventricular dysfunction impairs blood flow through the lung, leading to the left ventricle becoming underfilled. Intravenous volume infusion serves to correct hypotension.

46
Q

Which side of the papillary muscle is mostly subject to necrosis? why?

A

The posteromedial LV papillary muscle is more susceptible to infarction that the anterolateral one because it has a more precarious blood supply.

47
Q

How does ventricle wall rupture occur? Which groups of patients are at risk? What does it leads to?

A

Ventricle free wall rupture – rupture of the LV free wall through a tear in the necrotic myocardium may occur within the first 2 weeks following MI. It is more common among women and patient with hypertension. Hemorrhage into the pericardial space owing the LV free wall rupture results in rapid cardiac tamponade, in which blood fills the pericardial space and severely restricts ventricular filling. Survival is rare.
Pseudoaneurysm result if rupture of the free wall is incomplete and held in check by thrombus formation that “plug” the hole in the myocardium. This situation is the cardiac equivalent of a time bomb because subsequent complete rupture into the pericardium and tamponade could follow.

48
Q

What happens during ventricular septal rupture? Any physical finding?

A

Ventricular septal rupture – the blood is shunted across the ventricular septum from the left ventricle, usually precipitating congestive heart failure because of subsequent volume overload of the pulmonary capillaries. A loud murmur at the left sternal border, representing a transseptal flow. Ventricular septal rupture can be differentiated from acute mitral regurgitation by the location of the murmur, by Doppler echocardiography, or by measuring the O2 saturation of blood in the right-sided heart chambers through a transvenous catheter

49
Q

What happens during true ventricular aneurysm? Any examination finding?

A

True ventricular aneurysm – Develops as the ventricular wall is weakened by the phagocytic clearance of necrotic tissue, and it result in a localized dyskinesis when the residual viable heart muscle contract. Potential complication of LV aneurysm include (1) thrombus formation within this region of stagnant blood flow, serving as a source of emboli to peripheral organs; (2) ventricular arrhythmias associated with the stretched myofibers; and (3) heart failure resulting from reduced forward cardiac output, because some of the LV stroke volume is “waster” by filling the aneurysm cavity during systole. (Clue to the presence of an LV aneurysm include persistent ST-segment elevation on the EKG weeks after the acute ST-elevation MI).

50
Q

How does thromboembolism occur after MI?

A

Stasis of blood flow in regions of impaired LV contraction after an MI may result in intracavity thrombus formation, especially when the infarction involves the LV apex or when a true aneurysm has formed. This may result in infarction of peripheral organs.

51
Q

What are the management needed following myocardial infarction?

A

Standard postdischarge therapy for the long-term includes aspirin, a β-blocker, and a high-intensity HMG-CoA reductase inhibitor (statin). A P2Y12 platelet inhibitor is continued for 12 months or longer. ACE inhibitors are prescribed to patients who have LV contractile dysfunction; an aldosterone antagonist should be considered in those with heart failure symptoms. Rigorous attention to underlying cardiac risk factors, such as smoking, hypertension, and diabetes, is mandatory, and a formal exercise rehabilitation program often speeds convalescence.